Candriam Equities L Biotechnology Class I Fonds
4.624,60
GBP
+102,48
GBP
+2,27
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 5,34% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 4,41% |
| Insmed Inc | US4576693075 | 4,30% |
| Gilead Sciences Inc | US3755581036 | 4,09% |
| Amgen Inc | US0311621009 | 3,73% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 3,58% |
| United Therapeutics Corp | US91307C1027 | 2,77% |
| Ionis Pharmaceuticals Inc | US4622221004 | 2,48% |
| Roivant Sciences Ltd Ordinary Shares | BMG762791017 | 2,40% |
| Neurocrine Biosciences Inc | US64125C1099 | 2,22% |
| Sonstige | 64,69% |